Pridopidine
Pridopidine is a pharmaceutical drug with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
6
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
HEALEY ALS Platform Trial - Master Protocol
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD
HEALEY ALS Platform Trial - Regimen D Pridopidine
Clinical Trials (9)
HEALEY ALS Platform Trial - Master Protocol
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD
HEALEY ALS Platform Trial - Regimen D Pridopidine
A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9